Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension

Background. Blinded clinical trials have reported a modest and transient “start-up syndrome” with initiation of tenofovir-based pre-exposure prophylaxis (PrEP). We evaluate this phenomenon and its effect on adherence in an open-label PrEP study. Methods. In the iPrEx open-label extension (OLE) study...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Infect Dis
Main Authors: Glidden, David V., Amico, K. Rivet, Liu, Albert Y., Hosek, Sybil G., Anderson, Peter L., Buchbinder, Susan P., McMahan, Vanessa, Mayer, Kenneth H., David, Burns, Schechter, Mauro, Grinsztejn, Beatriz, Guanira, Juan, Grant, Robert M.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
HIV/AIDS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826449/
https://ncbi.nlm.nih.gov/pubmed/26797207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw022
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki